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Abstract
Background: Arthorpod-borne viruses (arboviruses) cause wide-spread morbidity in sub-Saharan Africa, but little
research has documented the burden and distribution of these pathogens.
Methods: Using a population-based, cross-sectional study design, we administered a detailed questionnaire and
used ELISA to test the blood of 1,141 healthy Kenyan adults from three districts for the presence of anti-viral
Immunoglobulin G (IgG) antibodies to the following viruses: dengue (DENV), West Nile (WNV), yellow fever (YFV),
Chikungunya (CHIKV), and Rift Valley fever (RVFV).
Results: Of these, 14.4% were positive for DENV, 9.5% were WNV positive, 9.2% were YFV positive, 34.0% were
positive for CHIKV and 0.7% were RVFV positive. In total, 46.6% had antibodies to at least one of these arboviruses.
Conclusions: For all arboviruses, district of residence was strongly associated with seropositivity. Seroprevalence to
YFV, DENV and WNV increased with age, while there was no correlation between age and seropositivity for CHIKV,
suggesting that much of the seropositivity to CHIKV is due to sporadic epidemics. Paradoxically, literacy was
associated with increased seropositivity of CHIKV and DENV.
Keywords: arbovirus, Kenya, flavivirus, dengue virus, West Nile virus, yellow fever virus, chikungunya virus, Rift Val-
ley fever virus
Background
Although there is a significant, increasing worldwide
impact of arboviruses from the Togaviridae, Flaviviridae
and Bunyaviridae families [1,2], they are poorly under-
stood and controlled. The recent epidemic of Chikungu-
nya virus (CHIKV) in the Indian Ocean Basin[3] has
demonstrated the ability of these viruses to spread far
beyond traditionally observed areas of distribution[4]
and to cause severe morbidity, mortality, and economic
harm[5]. Tropical Africa was likely the site of origin of
these viruses [6-8] and the burden of disease in this
region remains high but much is still not known about
their distribution and epidemiology in this region[2].
More is known about these diseases, their vectors and
various aspects of their transmission during epidemic
periods [3,9-13] than during endemic periods[14]. This
lack of epidemiologic knowledge stems in part from a
lack of surveillance capacity, with most resources for
study and control of these viruses being focused on epi-
demic periods. Kenya, located in East Africa (Figure 1),
is considered to be endemic for arboviruses from the
Togaviridae, Flaviviridae and Bunyaviridae families.
Competent vectors of these viruses (Aedes, Anopheles
and Culex mosquitoes) have been demonstrated
throughout Kenya.
Dengue virus (DENV) infection can cause a spectrum
of symptoms, from mild, non-specific symptoms to clas-
sic dengue fever, with high fevers and severe arthralgia.
Reinfection can lead to dengue hemorrhagic fever. In
1982 an outbreak of dengue fever occurred in Kenya
[15]. West Nile virus (WNV) infection is generally a
self-limited disease with mild symptoms but occasionally
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any medium, provided the original work is properly cited.causes encephalitis. It has been detected in Kenya’s mos-
quitoes [16]. Yellow fever virus (YFV) can cause severe
hepatitis and hemorrhagic fever. In 1992-3 an outbreak
occurred in Kenya[17]. YFV, WNV and DENV belong
to the Flaviviridae family. Infection with CHIKV (Toga-
viridae family) can cause headache, rash, nausea, vomit-
ing and prolonged, debilitating arthralgia. Areas of
coastal Kenya were shown to be greatly affected in the
recent outbreak of CHIKV [3,18]. Most infections with
Rift Valley fever virus (RVFV) (Bunyaviridae family) are
mild, but a small proportion of infections develop more
severe forms of the disease, including ocular, menin-
goencephalitis or hemorrhagic fever. There have been
outbreaks of RVFV in Kenya, most recently in 2006-
2007 [13]. Numerous studies have analyzed transmission
of this epizootic, arboviral disease during epidemic peri-
ods [13,19,20] as well as modeling to predict future out-
breaks [21]. There are fewer studies that explore the
characteristics of RVF during non-epidemic periods,
including several with human data [14,22] and others
with animal data [23,24]. Infection with these viruses
typically leads to antibody production in the serum.
Immunoglobulin M develops acutely and is short-lived,
while immunoglobulin G (IgG) develops shortly there-
after and is long-lasting.
In this report, we present the results of a population-
based, cross-sectional survey of IgG antibodies against
DENV, WNV, YFV, CHIKV and RVFV in Kenyan adults
from three districts. The objectives of this study were to
determine the endemic prevalence of arboviral illnesses
in three ecologically distinct districts in Kenya and to
determine the demographic, socioeconomic, and envir-
onmental factors associated with previous infection by
these viruses.
Methods
Ethics statement
The study was approved by Kenya Medical Research
Institute’s Ethical Review Committee and the Walter
Reed Army Institute of Research’s Division of Human
Subjects Protection. Potential candidates were invited
and those meeting all inclusion criteria who were willing
to participate and sign a written informed consent were
recruited. Study participants were tested for malaria on
the same day as the study and, if positive, were treated
with an artemisinin-containing combination anti-malar-
ial. This treatment constituted the study’s direct benefit
to participants.
Study design
This study utilized a population-based, cross-sectional
design. Two villages were selected from each of three
districts. The 6 study site villages were selected via two-
stage cluster sampling technique, with districts selected
ap r i o r iand sublocation and village subsequently
selected randomly, based on population proportional to
size. The districts selected, as well as their general geo-
graphic location were Malindi (Indian Ocean Coast),
Busia (Lake Victoria Basin), and Samburu (semi-arid
north). All districts have large rural populations. The
districts and villages selected are shown in Figure 1. Fol-
lowing consent, a standardized questionnaire was admi-
nistered, malaria smear performed and serum sample
obtained upon enrollment. Site selection, subject recruit-
ment, questionnaire administration, phlebotomy and
ELISA testing occurred between July and Sept 2004.
Study subjects
The study population consisted of all eligible, consenting
adults living in any of the six selected villages. Commu-
nity members and leaders were engaged prior to recruit-
ing study participants. Meetings were organized wherein
the study staff explained the study and answered any
questions in an open forum. Upon commencing partici-
pant recruitment, enrollment occurred in community
centers such as clinics or schools identified by commu-
nity leaders. Enrollment occurred only after verification
of potential subject eligibility, explaining the study in
the local language and giving the subjects an opportu-
nity to ask the field staff and study investigators any
questions. Criteria for exclusion were: age < 18 years,
residence in district <5 years, inability to give informed
consent or choosing not to participate. Criteria for
inclusion in the study were: absence of any exclusion
criteria, demonstration of understanding of the study
Figure 1 Map of Kenya with locations of study sites in Busia,
Malindi and Samburu districts sampled June-September 2004.
Map is shown in relation to annual precipitation. Darker areas
represent greater average precipitation, from a 50 year average.
Data from http://www.worldclim.org.
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senting subjects, witnessed informed consent was
obtained.
Questionnaire
The study questionnaire was developed to obtain demo-
graphic, socioeconomic and health information. Local
medical authorities participated in design of the ques-
tionnaire, which was modeled partly on the Kenya
Demographic and Health surveys from 1988-1989[25],
1998[26], and 2003[27]. The questionnaire was piloted
in communities similar to those in the actual study and
administered by trained interviewers. Before the inter-
view ended, it was verified that recorded questionnaire
responses were clear, complete, and internally
consistent.
Laboratory
Using standard precautions, study participants under-
went phlebotomy. Blood samples were then transported,
under cold storage, to the World Health Organization
(WHO) arbovirus reference laboratory in Nairobi,
Kenya. There the serum was separated from whole
blood, and serum samples were tested for IgG antibo-
dies against the study viruses. Testing was carried out
using IgG capture enzyme-linked immunosorbent assay
(ELISA). The ELISA reagents used were provided by the
Diagnostic Systems Division of the United States Army
Medical Research Institute of Infectious Diseases
(USAMRIID), USA. The reagents were indicated for
research purposes only. Their sensitivity and specificity
have not been fully characterized, however, they have
been used in numerous serosurveys and epidemics
throughout South America, Africa, and Asia
ELISA antigen
The detergent basic buffer extraction for viral antigen
preparation was previously described [28,29]. The
viruses utilized for ELISA antigen preparations were
Chikungunya (CHIKV), Indo23574 strain; yellow fever
(YFV), 17D strain; dengue 2 (DENV), New Guinea C
strain; West Nile (WNV), EG 101 strain; Rift Valley
fever (RVFV), ZH501 strain. Each virus was propagated
in African green monkey kidney (Vero) cells or Vero E6
cells, with the exception of RVFV, which grew in baby
hamster kidney (BHK) cells. Briefly, viruses were grown
in the appropriate cell line in roller bottles infected at a
low multiplicity of infection (MOI) until cytopathic
effects (CPE) were significant. Remaining attached cells
were scraped into the infected cell suspension and sepa-
rated from the supernatant by high-speed centrifugation.
The pelleted cells were resuspended in borate saline,
pelleted again, resuspended in borate saline with deter-
gent, and sonicated. Sonicated cell fragments were
pelleted by high-speed centrifugation and the superna-
tant collected for ELISA antigenic material. The cell
lysates of viral antigens were inactivated by addition of
0.3% beta-propiolactone (BPL) and incubation for
approximately 72 hr at 4°C, followed by gamma-irradia-
tion. Corresponding negative antigenic material was pre-
pared in the same fashion using uninfected cultured
cells. Since RVFV IgG ELISA used an indirect capture
sandwich ELISA, the antigenic material was only clari-
fied RVFV infected cell culture supernatant inactivated
as described above. All preparations were safety tested
to ensure all viruses were inactivated.
Detection of all virus specific IgG antibodies, except
RVFV, utilized the indirect ELISA format previously
described [28,29]. Briefly, one half of a 96-well polyvi-
nylchloride (PVC) microtiter plate was coated directly
with 100 µl/well of inactivated, detergent-extracted virus
infected cell lysate in 0.01 M phosphate-buffered saline
(pH 7.4) with 0.01% thimerosal (coating buffer) at a pre-
determined optimal dilution. Antigen was optimized
using known positive human or animal serum. The
other plate half was coated with 100 µl/well of the
appropriate corresponding negative cell antigenic pre-
paration. Plates were wrapped in plastic wrap and incu-
bated at 4°C overnight.
The next day plates were washed three times with
wash buffer (coating buffer and 0.3% Tween-20). All
subsequent reagents added to the plates were diluted in
reagent buffer (wash buffer containing 5% skim milk).
After the addition of each reagent, the plates were incu-
bated in a moist environment at 37°C for 1 hr and then
washed three times. Serum samples were diluted to
obtain a final 1:100 dilution when added into both posi-
tive and negative coated wells. Positive control serum
from native infections or vaccine recipients was used to
monitor reproducibility of assays. Four negative control
sera were included for each assay to determine the opti-
cal density (OD) cut-off value. After addition of serum,
plates were incubated for 1 hr at 37°C and subsequently
washed. Conjugate was a mouse anti-human IgG (FC)
serum conjugated with peroxidase (Accurate Chemical
& Scientific Corp, Cat. No. JMH035103, Westbury, NY)
at a dilution determined by previous titration. The sub-
strate, 100 µl of 1:1 ABTS (2.2-azino-di [3-etil-benztia-
zolin sulfonato] (Kirkergard and Perry, Cat. No. N8
50-62-00, Gaithersburg, MD) and hydrogen peroxide
(H2O2), was added to each well to complete the reac-
tion. After 30 min incubation, plates were read spectro-
photometrically at 405 nm. For detection of RVFV
antibodies, a capture or sandwich assay was used. This
assay was performed as described above, except the
PVC microtiter wells were initially coated with an opti-
mized dilution of a nucleocapsid-specific monoclonal
antibody that captures the inactivated RVFV antigen.
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OD of the negative antigen coated wells from the posi-
tive antigen coated wells. The OD cut-off was calculated
as the mean of the adjusted OD of the negative control
sera plus three times the standard deviations, generally
an OD of ≤ 0.2 at a 1:100 sample dilution. A serum
sample was considered positive if the adjusted OD value
was greater than or equal to the assay cut-off or 0.2,
which ever value was higher.
Data analysis
The main outcomes of interest were IgG antibodies
against: DENV, WNV, YFV, flaviviruses (using com-
bined data from YFV, DENV and WNV), CHIKV and
RVFV. For each outcome we calculated overall seroposi-
tivity rates. The following variables from the question-
naire were selected, ap r i o r i , for analysis: age (18-25,
26-35, 36-45 and 46+ years old), sex, literacy (defined by
self-reported ability to read a newspaper), occupational
group (agriculture, home duties or other) and roofing
type (thatch, corrugated metal or wood/mud/concrete).
Not all variables from the questionnaire were included
in the data analysis. Selection of variables to include was
based on author consensus and pertinence to arbovirus
epidemiology (i.e. many of the questions regarding
malaria-specific risk factors were omitted).
IgG status was recorded and analyzed as a dichoto-
mous variable (positive or negative). Data entry
described previously[30]. Stata version 10 IC for Win-
dow (Stata Corp., College Station, TX) was used for all
statistical analysis.
Prior to commencement of the study, sample size cal-
culations determined that at least 204 participants
would be required from each district, using a hypotheti-
cal comparison ratio positive (percentage IgG positive)
of 0.00, a hypothesized ratio positive (level considered
epidemiologically significant) 0.05, alpha 0.05, power 0.9
and one-sided testing.
We calculated descriptive statistics for questionnaire
variables. c
2 and Fisher’se x a c tt e s t sw e r eu s e dt oe v a l u -
ate heterogeneity of rates among the different districts.
Using unadjusted logistic regression models we exam-
ined the effects of sex and age, individually, on the odds
of seropositivity to alphaviruses, flaviviruses, YFV,
DENV and WNV. We subsequently evaluated self-
reported literacy, home roofing material, and occupation
on odds of seropositivity, using logistic regression mod-
els adjusting for age and sex.
Increased mobility (measured by bicycle ownership),
having children at home and differences in housing type
(measured by roof type) were considered as possible
confounders of the effect of literacy on seropositivity.
Separate logistic models were constructed, controlling
for age, sex and, one by one, these possible confounders.
District of residence was considered a possible confoun-
der of the effect of roofing material; to control for this
the effect of roofing material was evaluated by logistic
regression modeling after stratifying by district of resi-
dence. For RVFV, associations between seropositivity
and age, sex, formal education, home roofing material
and occupation were examined using Fisher’se x a c tt e s t .
To further increase statistical power, these analyses were
performed twice using 2-way Fisher’s exact test, exclud-
ing either Malindi or Samburu district. If data was miss-
ing regarding the outcome or covariate of interest in
statistical analysis, this observation was omitted.
Results
Demographics of the study population are summarized
in Table 1. The sampled areas represent a predomi-
nantly rural populace. 1,141 total subjects were enrolled,
representing 27.8% of the adult population of the
selected villages. 461 participants were from Busia, 442
from Malindi and 238 were from Samburu. 731 (64.1%)
were female and 410 (35.9%) were male. There was a
difference in sex distribution among the different age
ranges in all districts, with younger females more pro-
portionally represented than younger males (p < 0.001).
There was, however, no statistically significant difference
in the age or sex distribution of subjects among the
three districts. Results of serological testing, stratified by
district, are summarized in Table 2. Previously published
data on malaria parasitemia[30], representing the same
participants and collection dates as this study, are
included in the table for comparison purposes.
Table 3 summarizes the association between sociode-
mographic factors and anti-arboviral IgG seropositivity
using logistic regression. There was significant heteroge-
neity of seroprevalence for all arboviruses by district,
using c
2 and Fisher’s exact test with p < 0.001 in all
cases, but no significant heterogeneity of seroprevalence
between study sites within the same district. For flavi-
viruses there was no significant difference in the propor-
tion of seropositive individuals between Busia and
Samburu; in both districts seroprevalence was <5% for
all individual flaviviruses. All RVFV positives were from
the Samburu district except one. This individual was
from Malindi district and reported never having lived
outside that district.
Lower seroprevalence of CHIKV antibodies was noted
among illiterate participants when compared to those
who reported being able to read easily (OR 0.45 (0.33-
0.62)). Similarly, for DENV, those who reported being
able to read with difficulty had lower odds of seroposi-
tivity than those would could read easily (OR 0.59 (0.36-
0.99)). Having children at home, increased mobility
(measured by bicycle ownership) and housing type
(measured by roofing type) were considered as possible
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nificant association of decreased seroprevalence among
illiterate study participants persisted after controlling for
each of these variables individually.
For CHIKV, higher odds of antibody seroprevalence
were seen among those with corrugated metal and
thatch roofs and as compared to those with wood/mud/
concrete roofing. Corrugated metal and thatch roofing
were associated with increased odds of antibodies
against flaviviruses. Similarly, significantly increased
odds of seropositivity to DENV, WNV, and YFV were
noted among those with corrugated metal or thatch
roofs. To control for potential confounding due to use
of different types of roofing materials in distinct geo-
graphic settings, logistic regression was performed after
stratifying by district. No significant association
remained for any virus or group following stratification,
which suggests that associations between housing mate-
rials and arbovirus seropositivity are strongly con-
founded by district of residence.
Possible associations between RVFV antibody seropo-
sitivity and district of residence, age, sex, literacy, occu-
pation, or roofing material were tested using Fisher’s
exact test. RVFV antibody seropositivity was significantly
associated with district of residence (p < 0.001). No sta-
tistically significant association was noted for age, sex,
literacy, occupation, or roofing material, both within
analyses that included all districts, and those that
excluded Malindi and Busia in turn.
Discussion
Arboviral infections are considered a serious public
health problem in tropical Africa; this study confirms
that a large proportion of adults in rural Kenya have
been infected by arboviruses at some point in their life.
The true burden of disease from arboviral infections
cannot be measured with a cross-sectional study, but
this data suggests that it is high in rural Kenya. Further-
more, this study only detected those who survived arbo-
viral infection, ignoring the burden caused by mortality
from arboviral infections in the communities sampled.
The proportion of individuals with evidence of arbo-
viral infection differed significantly between districts;
however no difference was detected between different
study sites within the districts tested. A different virus
was found to be most prominent in each of the three
districts tested; CHIKV infection was most prevalent in
Table 1 Sociodemographic characteristics of study
participants by district (n = 1141)
District Busia
n = 461
Malindi
n = 442
Samburu
n = 238
Missing Total n
= 1141
Sex 2
Female 298 281 152 731
Male 161 161 86 408
Age 0
18-25 98 116 52 266
26-35 109 121 56 286
36-45 90 85 44 219
> 45 164 120 86 370
Literacy
a 8
Easily 183 203 40 426
With
difficulty
140 53 27 220
Not at all 136 184 167 487
Occupation 31
Other
b 128 159 50 337
Agriculture 300 223 83 606
Home Duty 13 50 104 167
Roof Type 0
Wood,
Mud,
Concrete
2 3 108 113
Corrugated
Metal
187 108 42 337
Thatch 272 331 88 691
Table 2 Prevalence of anti-arboviral IgG antibodies by district, Kenya, September 2004 (n = 1141)
Busia % (n)
c Malindi Samburu Missing Total Positive
Any Arbovirus 62.09 (285) 51.58 (228) 6.47 (15) 8 46.60 (528)
Flaviviruses (all pos.)
d,e 6.97 (32) 37.78 (167) 4.31 (10) 8 18.50 (209)
Flaviviruses (multiple pos.) 1.96 (9) 20.81 (92) 0.86 (2) 14 9.09 (103)
DENV (all pos.) 1.96 (9) 34.17 (149) 1.72 (4) 14 14.40 (162)
DENV (sole pos.)
f 0.44 (2) 13.67 (60) 1.29 (3) 14 5.77 (65)
WNV (all pos.) 4.36 (20) 18.81 (82) 2.16 (5) 14 9.49 (107)
WNV (sole pos.) 3.05 (14) 2.29 (10) 1.29 (3) 14 2.40 (27)
YFV (all pos.) 3.49 (16) 19.27 (84) 1.72 (4) 14 9.23 (104)
YFV (sole pos.) 1.53 (7) 1.15 (5) 0.86 (2) 14 1.24 (14)
CHIKV 59.91 (275) 24.77 (108) 0.00 (0) 14 34.00 (383)
RVFV 0.00 0.23 (1) 3.02 (7) 32 0.72 (8)
Malaria
g 22.34 (103) 7.24 (32) 1.68 (4) 0 12.2 (139)
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buru. This finding suggest that the risk of infection
from arboviral disease differs significantly between dif-
ferent areas of Kenya, but that within a district, the risk
is relatively homogenous. This has public health impli-
cations, suggesting that prevention programs (or in the
case of an outbreak, investigation and intervention
efforts) should be virus or genus-specific. Furthermore,
these efforts might be most effectively targeted at a dis-
trict level, as opposed to country-wide, which would be
too broad or village-specific, which might be too
narrow.
The absence of association between age and CHIKV
seropositivity suggests that the predominant cause of
seropositivity among this group of Kenyan adults may
be exposure to infected mosquitoes during one or more
outbreaks. In contrast, for flaviviruses, the association of
increasing age with increasing seroprevalence suggests
more stable rates of ongoing transmission among the
population tested.
The finding that illiteracy seems to be protective
against infection with CHIKV and DENV was not
entirely unexpected, as a similar finding of lower odds
of malaria parasitemia among illiterate participants was
noted in a previous publication from this study [30]. It
is still surprising, as literacy is generally associated with
increased socioeconomic status, increased access to pre-
ventive measures and more developed habitation, all
which would presumably lead to a lower risk of expo-
sure to infected mosquitoes. Possible explanations for
this finding include increased mobility among those who
are literate and school attendance by their children,
allowing more potential for exposure at multiple loca-
tions, among the tested adults and their children. How-
ever, the association of increased seropositivity among
literate participants persisted even after controlling, indi-
vidually, for increased mobility (measured by bicycle
ownership) and having children at home. Different
housing type (as measured by roofing type) was also
considered as a possible confounder but the association
of increased seropositivity among literate participants
also persisted after controlling for this. This paradoxical
finding may be due to bias or confounding from an
unmeasured variable, but it appears to be internally
valid, since it is consistent for multiple agents (CHIKV,
DENV and malaria.)
Housing type (measured by roofing type) may be an
important risk factor in exposure to infected
Table 3 Factors associated with anti-arboviral IgG seropositivity among rural adults in logistic regression, Kenya,
September 2004
Flavivirus DENV WNV YFV CHIKV
District OR (95% CI)
h OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Busia Reference Reference Reference Reference Reference
Malindi 8.1 (5.39-12.18)
i 25.96 (13.03-51.69) 5.08 (3.06-8.45) 6.61 (3.8-11.48) 0.22 (0.17-0.29)
Samburu 0.6 (0.29-1.25) 0.88 (0.27-2.88) 0.48 (0.18-1.31) 0.49 (0.16-1.47) No values
Sex
Female Reference Reference Reference Reference Reference
Male 1.08 (0.79-1.48) 1.07 (0.76-1.52) 1.41 (0.94-2.11) 1.31 (0.87-1.97) 1.04 (0.81-1.35)
Age
18-25 Reference Reference Reference Reference Reference
26-35 1.54 (0.94-2.5) 1.51 (0.86-2.65) 1.8 (0.89-3.61) 2.28 (1.02-5.07) 1.16 (0.81-1.65)
36-45 2.24 (1.37-3.65) 2.77 (1.6-4.79) 2.6 (1.3-5.2) 4.5 (2.09-9.71) 0.89 (0.6-1.31)
46+ 2.09 (1.33-3.27) 2.24 (1.34-3.75) 2.64 (1.39-5) 3.87 (1.85-8.07) 1.2 (0.86-1.68)
Literacy
j,a
Easily Reference Reference Reference Reference Reference
With difficulty 0.7 (0.48-1.04) 0.59 (0.36-0.99)
h 0.57 (0.3-1.08) 0.58 (0.31-1.09) 0.96 (0.68-1.35)
Not at all 0.9 (0.62-1.31) 0.74 (0.49-1.12) 0.97 (0.59-1.58) 0.76 (0.46-1.26) 0.45 (0.33-0.62)
Occupation
j
Other
b Reference Reference Reference Reference Reference
Agriculture 0.84 (0.59-1.2) 0.82 (0.55-1.22) 1.11 (0.69-1.78) 0.97 (0.6-1.56) 1.22 (0.91-1.64)
Home Duty 0.62 (0.36-1.06) 0.67 (0.37-1.22) 0.55 (0.24-1.26) 0.62 (0.28-1.37) 0.23 (0.14-0.4)
Roof Type
j
Wood, Mud, Concrete Reference Reference Reference Reference Reference
Corrugated Metal 6.5 (1.98-21.31) 7.62 (1.81-32.13) 10.69 (1.44-79.54) 4.92 (1.15-21.12) 76.86 (10.6-557.45)
Thatch 11.86 (3.7-38.03) 13.15 (3.19-54.2) 15.67 (2.15-114.22) 7.8 (1.88-32.41) 65.13 (9.03-469.88)
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roofing type and arbovirus seroprevalence lost statistical
significance after controlling for district of residence,
suggesting that any association between housing materi-
als and arbovirus seropositivity is strongly confounded
by district of residence.
This study is limited by the lack of validated ELISA
assays and plaque reduction neutralization tests
(PRNTs) to increase the specificity of ELISA testing and
reduce potential cross reactivity at the time the study
was conducted. The lack of non-validated assays engen-
ders inherent uncertainty int h er e s u l t so ft h i ss t u d y .
Further uncertainty is engendered by the unavailability
of confirmatory plaque reduction neutralization tests
(PRNTs). This highlights the need for the increased
availability of affordable, validated assays for use in clini-
cal, surveillance and research settings. An important
limitation is potential cross-reactivity between CHIKV
and O’nyong-nyong virus (ONNV). Belonging to the
same genus and causing similar symptoms, CHIKV and
ONNV are also highly related. Because of similar anti-
genic structure, there is often a high level of antibody
cross-reactivity. Cross-reactivity between these viruses is
well documented [31,32] and so high that any positive
CHIKV result could be almost equally due to either
CHIKV or ONNV. The results of this study should be
interpreted in light of this. Although not at the level
expected for CHIKV and ONNV, cross-reactivity
between the flaviviruses tested in this study is also well-
documented and the results should be interpreted
accordingly. Another limitation is that the data were
collected several years ago, notably prior to the most
recent outbreaks of CHIKV and RVFV affecting Kenya.
While these data may not reflect the current status of
seroprevalence in the areas tested, they also provide pos-
sible pre-outbreak baselines of CHIKV seroprevalence in
coastal Kenya and RVFV seropositivity in central Kenya.
The exclusion of individuals under the age of 18 is
another potential limitation, as the pediatric population
in these communities must play an important role in
the epidemiology of the infections studied.
Conclusions
In conclusion, we found that a large proportion of rural
Kenyan adults have been infected by arboviruses. Several
sociodemographic factors were associated with arboviral
seropositivity. Most of these were expected, for example
the difference in seroprevalence seen between districts
and the increasing odds of seropositivity seen with
increasing age for flaviviruses. Other findings, such as
the absence of association between CHIKV and age, and
the apparent protective effect against arboviral infection
among illiterate participants have not been well
described in the literature and merit further study.
Endnotes
a. Literacy was measured by self-reported ability to read
a newspaper.
b. Other category for Occupation includes those who
reported work in small business, large business, civil ser-
vice, transport, tourism, formal employment, work as
casual laborers or unemployed.
c. % and (n) represent the percent and number within
the given district with antibodies to the corresponding
virus.
d. Pos., positive.
e. Flavivirus category presents summation for specific
tests for DENV, WNV and YFV.
f. Sole pos. indicates number of individuals positive for
only that flavivirus and no other flavivirus. Those
included may or may not be positive for alphavirus and
RVF.
g. Malaria data included for comparison purposes
only. It represents same participants and collection
dates as this study, previously published[30].
h. OR, odds ratio; CI, confidence interval.
i. Statistically significant odds ratios (P-value ≤ 0.05)
are indicated in bold.
j. Controlled for age and sex in multivariate logistic
regression.
Abbreviations
CHIKV: Chikungunya virus; DENV: dengue virus; ELISA: enzyme-linked
immunosorbent assay; OONV: O’nyon-nyong virus; PRNT: plaque reduction
neutralization test; RVFV: Rift Valley fever virus; WNV: West Nile virus; YFV:
yellow fever virus.
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